Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Apr 1:14:865244.
doi: 10.3389/fnagi.2022.865244. eCollection 2022.

Systemic-Immune-Inflammation Index as a Promising Biomarker for Predicting Perioperative Ischemic Stroke in Older Patients Who Underwent Non-cardiac Surgery

Affiliations

Systemic-Immune-Inflammation Index as a Promising Biomarker for Predicting Perioperative Ischemic Stroke in Older Patients Who Underwent Non-cardiac Surgery

Faqiang Zhang et al. Front Aging Neurosci. .

Erratum in

Abstract

Objective: This study aimed to investigate the clinical prognostic values of the preoperative systemic-immune-inflammation index (SII) in older patients undergoing non-cardiac surgery, using perioperative ischemic stroke as the primary outcome.

Methods: This retrospective cohort study included older patients who underwent non-cardiac surgery between January 2008 and August 2019. The patients were divided into SII < 583 and SII ≥ 583 group according to the optimal SII cut-off value. The outcome of interest was ischemic stroke within 30 days after surgery. Primary, sensitivity, and subgroup analyses were performed to confirm that preoperative SII qualifies as a promising, independent prognostic indicator. Propensity score matching (PSM) analysis was further applied to address the potential residual confounding effect of covariates to examine the robustness of our results.

Results: Among the 40,670 included patients with a median age of 70 years (interquartile range: 67, 74), 237 (0.58%) experienced an ischemic stroke within 30 days after surgery. SII ≥ 583 was associated with an increased risk of perioperative ischemic stroke in multivariate regression analysis [odds ratio (OR), 1.843; 95% confidence interval (CI), 1.369-2.480; P < 0.001]. After PSM adjustment, all covariates were well balanced between the two groups. The correlation between the SII and perioperative ischemic stroke remained significantly robust (OR: 2.195; 95% CI: 1.574-3.106; P < 0.001) in the PSM analysis.

Conclusion: Preoperative SII, which includes neutrophil, platelet, and lymphocyte counts obtained from routine blood analysis, was a potential prognostic biomarker for predicting perioperative ischemic stroke after non-cardiac surgery in elderly older patients. An elevated SII, based on an optimal cut-off value of 583, was an independent risk factor for perioperative ischemic stroke.

Keywords: biomarker; inflammation; older patients; perioperative stroke; postoperative complication; systemic-immune-inflammation index (SII).

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

FIGURE 1
FIGURE 1
Study profile. ASA, American Society of Anesthesiologists; PSM, propensity score matching.
FIGURE 2
FIGURE 2
Distribution of propensity scores before and after matching.
FIGURE 3
FIGURE 3
Incidence of perioperative ischemic stroke among the different surgical procedures.
FIGURE 4
FIGURE 4
Subgroup analyses of the association between SII and perioperative ischemic stroke. OR, odds ratio; MAP, mean arterial pressure.

Similar articles

Cited by

References

    1. Aziz M. H., Sideras K., Aziz N. A., Mauff K., Haen R., Roos D., et al. (2019). The Systemic-immune-inflammation Index Independently Predicts Survival and Recurrence in Resectable Pancreatic Cancer and its Prognostic Value Depends on Bilirubin Levels: A Retrospective Multicenter Cohort Study. Annal. Surgery 270 139–146. 10.1097/SLA.0000000000002660 - DOI - PubMed
    1. Baker D., Herrod S. S., Alvarez-Gonzalez C., Giovannoni G., Schmierer K. (2017). Interpreting Lymphocyte Reconstitution Data From the Pivotal Phase 3 Trials of Alemtuzumab. JAMA Neurol 74 961–969. 10.1001/jamaneurol.2017.0676 - DOI - PMC - PubMed
    1. Boyle S., White R. H., Brunson A., Wun T. (2013). Splenectomy and the incidence of venous thromboembolism and sepsis in patients with immune thrombocytopenia. Blood 121 4782–4790. 10.1182/blood-2012-12-467068 - DOI - PMC - PubMed
    1. Chan L. W., Wang X., Wei H., Pozzo L. D., White N. J., Pun S. H. (2015). A synthetic fibrin cross-linking polymer for modulating clot properties and inducing hemostasis. Sci. Transl. Med. 7:277ra29. 10.1126/scitranslmed.3010383 - DOI - PMC - PubMed
    1. Cheung K. S., Chan E. W., Chen L., Seto W. K., Wong I. C. K., Leung W. K. (2019). Diabetes Increases Risk of Gastric Cancer After Eradication: A Territory-Wide Study With Propensity Score Analysis. Diabetes Care 42 1769–1775. 10.2337/dc19-0437 - DOI - PubMed